Clinical and microbiologic features of <i>Achromobacter</i> species: a 10-year, multicenter experience
David Bayless(Mayo Clinic), Omar M. Abu Saleh(Mayo Clinic), Nischal Ranganath, Mitchell Dumais(Mayo Clinic), Jack McHugh(Mayo Clinic), Supavit Chesdachai(Mayo Clinic), Madiha Fida(Mayo Clinic)
Cited by 10
Related Papers
Retrospective Analysis of Antimicrobial Susceptibility Profiles of <i>Nocardia</i> Species from a Tertiary Hospital and Reference Laboratory, 2011 to 2017
|Antimicrobial Agents and Chemotherapy|2019|101
Diagnostic Value of 16S Ribosomal RNA Gene Polymerase Chain Reaction/Sanger Sequencing in Clinical Practice
|Clinical Infectious Diseases|2021|59
Detection of Pathogenic Bacteria From Septic Patients Using 16S Ribosomal RNA Gene–Targeted Metagenomic Sequencing
|Clinical Infectious Diseases|2021|58
Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trial
|The Lancet Microbe|2024|50
Management and treatment of Aerococcus bacteremia and endocarditis
|International Journal of Infectious Diseases|2020|44